These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19198649)

  • 1. Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends.
    Ghani AC; Sutherland CJ; Riley EM; Drakeley CJ; Griffin JT; Gosling RD; Filipe JA
    PLoS One; 2009; 4(2):e4383. PubMed ID: 19198649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine.
    McCarthy KA; Wenger EA; Huynh GH; Eckhoff PA
    Malar J; 2015 Jan; 14():6. PubMed ID: 25563798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequences of reducing transmission of Plasmodium falciparum in Africa.
    Snow RW; Marsh K
    Adv Parasitol; 2002; 52():235-64. PubMed ID: 12521262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study.
    Katureebe A; Zinszer K; Arinaitwe E; Rek J; Kakande E; Charland K; Kigozi R; Kilama M; Nankabirwa J; Yeka A; Mawejje H; Mpimbaza A; Katamba H; Donnelly MJ; Rosenthal PJ; Drakeley C; Lindsay SW; Staedke SG; Smith DL; Greenhouse B; Kamya MR; Dorsey G
    PLoS Med; 2016 Nov; 13(11):e1002167. PubMed ID: 27824885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.
    Penny MA; Maire N; Studer A; Schapira A; Smith TA
    PLoS One; 2008 Sep; 3(9):e3193. PubMed ID: 18784833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing Impact: Can Interventions to Prevent Clinical Malaria Reduce Parasite Transmission?
    McCann RS; Cohee LM; Goupeyou-Youmsi J; Laufer MK
    Trends Parasitol; 2020 Nov; 36(11):906-913. PubMed ID: 32917511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive interventions for optimizing malaria control: an implementation study protocol for a block-cluster randomized, sequential multiple assignment trial.
    Zhou G; Lee MC; Atieli HE; Githure JI; Githeko AK; Kazura JW; Yan G
    Trials; 2020 Jul; 21(1):665. PubMed ID: 32690063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal vaccination and bednet maintenance for the control of malaria in a region with naturally acquired immunity.
    Prosper O; Ruktanonchai N; Martcheva M
    J Theor Biol; 2014 Jul; 353():142-56. PubMed ID: 24641821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa.
    Snow RW; Omumbo JA; Lowe B; Molyneux CS; Obiero JO; Palmer A; Weber MW; Pinder M; Nahlen B; Obonyo C; Newbold C; Gupta S; Marsh K
    Lancet; 1997 Jun; 349(9066):1650-4. PubMed ID: 9186382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of malaria interventions on child mortality in endemic African settings: comparison and alignment between LiST and Spectrum-Malaria model.
    Korenromp E; Hamilton M; Sanders R; Mahiané G; Briët OJT; Smith T; Winfrey W; Walker N; Stover J
    BMC Public Health; 2017 Nov; 17(Suppl 4):781. PubMed ID: 29143637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model.
    Filipe JA; Riley EM; Drakeley CJ; Sutherland CJ; Ghani AC
    PLoS Comput Biol; 2007 Dec; 3(12):e255. PubMed ID: 18166074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mathematical model of the impact of present and future malaria vaccines.
    Wenger EA; Eckhoff PA
    Malar J; 2013 Apr; 12():126. PubMed ID: 23587051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity to pre-erythrocytic stage malaria.
    Schwenk RJ; Richie TL
    Trends Parasitol; 2011 Jul; 27(7):306-14. PubMed ID: 21435951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria vaccines: a toy for travelers or a tool for eradication?
    Genton B
    Expert Rev Vaccines; 2008 Jul; 7(5):597-611. PubMed ID: 18564015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounting for regional transmission variability and the impact of malaria control interventions in Ghana: a population level mathematical modelling approach.
    Awine T; Silal SP
    Malar J; 2020 Nov; 19(1):423. PubMed ID: 33228659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the relative abundance of the primary African vectors of malaria before and after the implementation of indoor, insecticide-based vector control.
    Sinka ME; Golding N; Massey NC; Wiebe A; Huang Z; Hay SI; Moyes CL
    Malar J; 2016 Mar; 15():142. PubMed ID: 26945997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.